This site is intended only for healthcare professionals in Hong Kong SAR.

Our medicinesOur medicinesBesponsaCibinqoCresembaEliquisEnbrelIbranceLorviquaNgenlaNurtecPaxlovidPrevenar20PristiqTalzennaVizimproVyndamaxXeljanzZaviceftaSee All productsPfizer Hong Kong Price ListTherapy areasTherapy areasMultiple MyelomaNon-Small-Cell Lung CancerRespiratory Syncytial VirusTransthyretin AmyloidosisSearch



Sign InLog Out
Explore contentExplore contentEventsDownloadable materialsVideosLet’s connectLet's ConnectContact usPfizer medical information
About NSCLCIntroduction to NSCLCDefinition and staging of NSCLCPrevalence and incidence of NSCLCUnderstanding the nature of NSCLCEvolution of understanding of NSCLC Molecular subtypes of NSCLC Prognosis for patients with NSCLCPatient impact of NSCLCStigma and impact of lung cancer



DiagnosisTreatment OptionsTreatment options for oncogene-driven NSCLCIntroductionTreatment options for EGFRm NSCLCEGFRm: IntroductionEGFRm: Treatment optionsEGFRm: Disease progressionTreatment options for ALK+ NSCLCALK+: IntroductionALK+: Treatment optionsALK+: Disease progressionTreatment options for ROS1+ NSCLCROS1+: IntroductionROS1+: Treatment optionsROS1+: Disease progressionTherapy ManagementTherapy management approachesMultidisciplinary careShared decision-makingPatient communicationMinimizing adverse eventsPatient education on AEsProphylactic managementManaging patients with adverse eventsManaging adverse events Understanding the patient perspectiveSupporting ResourcesMaterialsVideos

Patient safety is of paramount importance throughout the life cycle of a medicine - and pharmaceutical companies have ethical and regulatory responsibilities to monitor the safety of the products they sell for as long as they are used by consumers anywhere in the world. The Drug Safety Unit at Pfizer Corporation Hong Kong Limited. address product experience reports including adverse events. If you have any experience pertinent to the above, please contact us at (852) 2811 9711 as soon as possible.

PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign inRegisterAccountSign Out

This site is intended only for healthcare professionals resident in to Hong Kong. If you are a member of the public wishing to access information on a specific medicine, please visit


The information provided in this site is intended only for Health Professionals who reside in Hong Kong, and the products discussed herein may have different product labeling in different countries/regions. The site is for information purpose only, and nothing herein shall be construed as providing any kind of medical advice or recommendation or product promotion. Pfizer Corporation Hong Kong Limited is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.


Copyright© 2023 Pfizer Corporation Hong Kong Limited. All rights reserved.

PP-UNP-HKG-0116 MAY 2023

You are leaving the PfizerPro Hong Kong website

You are being directed to a third-party website:

Please note that this third-party website is not controlled by PfizerPro Hong Kong or subject to our privacy policy.

Thank you for visiting our site. We hope your visit was informative and enjoyable.
PP-UNP-HKG-0076. May 2023​​​​​​​